Habtamu A Betelle

Array ( [id] => 7066010 [patent_doc_number] => 20010044616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Surgical irrigation solution and method for inhibition of pain and inflammation' [patent_app_type] => new [patent_app_number] => 09/837141 [patent_app_country] => US [patent_app_date] => 2001-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27917 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044616.pdf [firstpage_image] =>[orig_patent_app_number] => 09837141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586447 [patent_doc_number] => 06359005 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Method for the treatment of mania and bipolar disorder' [patent_app_type] => B1 [patent_app_number] => 09/807484 [patent_app_country] => US [patent_app_date] => 2001-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1477 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359005.pdf [firstpage_image] =>[orig_patent_app_number] => 09807484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6892296 [patent_doc_number] => 20010018458 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-30 [patent_title] => 'Method for treating asthma utilizing optically pure ( R ) - salmeterol' [patent_app_type] => new [patent_app_number] => 09/829553 [patent_app_country] => US [patent_app_date] => 2001-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2699 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20010018458.pdf [firstpage_image] =>[orig_patent_app_number] => 09829553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1398522 [patent_doc_number] => 06531457 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-11 [patent_title] => 'Methods and compositions for treating inflammatory response' [patent_app_type] => B2 [patent_app_number] => 09/827083 [patent_app_country] => US [patent_app_date] => 2001-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 16 [patent_no_of_words] => 12682 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531457.pdf [firstpage_image] =>[orig_patent_app_number] => 09827083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1535029 [patent_doc_number] => 06489337 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-03 [patent_title] => 'Method for treating histamine H3 receptor-mediated disorders with 2- or 3-aryl substituted imidazo1,2-a pyridines' [patent_app_type] => B1 [patent_app_number] => 09/820418 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8907 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/489/06489337.pdf [firstpage_image] =>[orig_patent_app_number] => 09820418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1560252 [patent_doc_number] => 06436939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-08-20 [patent_title] => 'Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as H3 antagonists' [patent_app_type] => B2 [patent_app_number] => 09/821215 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7659 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436939.pdf [firstpage_image] =>[orig_patent_app_number] => 09821215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416609 [patent_doc_number] => 06521634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-18 [patent_title] => 'Uses of dl-THP' [patent_app_type] => B2 [patent_app_number] => 09/819367 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 3897 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521634.pdf [firstpage_image] =>[orig_patent_app_number] => 09819367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1342575 [patent_doc_number] => 06586414 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-07-01 [patent_title] => 'Treatment of cerebrovascular disease' [patent_app_type] => B2 [patent_app_number] => 09/820199 [patent_app_country] => US [patent_app_date] => 2001-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14215 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586414.pdf [firstpage_image] =>[orig_patent_app_number] => 09820199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636481 [patent_doc_number] => 06380176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-04-30 [patent_title] => 'Method for inhibiting non-intentional behavior with a running neuron inhibitory substance' [patent_app_type] => B2 [patent_app_number] => 09/816396 [patent_app_country] => US [patent_app_date] => 2001-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4155 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380176.pdf [firstpage_image] =>[orig_patent_app_number] => 09816396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1524111 [patent_doc_number] => 06353015 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Method of treating neurodegenerative disorders' [patent_app_type] => B1 [patent_app_number] => 09/673451 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 9605 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/353/06353015.pdf [firstpage_image] =>[orig_patent_app_number] => 09673451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495733 [patent_doc_number] => 06403645 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-06-11 [patent_title] => 'Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them' [patent_app_type] => B2 [patent_app_number] => 09/811235 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2291 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403645.pdf [firstpage_image] =>[orig_patent_app_number] => 09811235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6886758 [patent_doc_number] => 20010020027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-06 [patent_title] => 'Treatment of depression' [patent_app_type] => new [patent_app_number] => 09/809470 [patent_app_country] => US [patent_app_date] => 2001-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2082 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20010020027.pdf [firstpage_image] =>[orig_patent_app_number] => 09809470 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6961888 [patent_doc_number] => 20010012849 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-09 [patent_title] => 'Pharmaceutical composition and method for treatment of inflammation' [patent_app_type] => new [patent_app_number] => 09/797022 [patent_app_country] => US [patent_app_date] => 2001-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3998 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20010012849.pdf [firstpage_image] =>[orig_patent_app_number] => 09797022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1396943 [patent_doc_number] => 06541477 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-01 [patent_title] => 'Inhibitors of p38-a kinase' [patent_app_type] => B2 [patent_app_number] => 09/796997 [patent_app_country] => US [patent_app_date] => 2001-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 9423 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541477.pdf [firstpage_image] =>[orig_patent_app_number] => 09796997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586482 [patent_doc_number] => 06359015 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Method for antagonizing inhibition effects of alcohol on cell adhesion' [patent_app_type] => B1 [patent_app_number] => 09/793533 [patent_app_country] => US [patent_app_date] => 2001-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 5723 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359015.pdf [firstpage_image] =>[orig_patent_app_number] => 09793533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5923104 [patent_doc_number] => 20020115635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-22 [patent_title] => 'Modulation of GSK-3beta activity and its different uses' [patent_app_type] => new [patent_app_number] => 09/788477 [patent_app_country] => US [patent_app_date] => 2001-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 5407 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20020115635.pdf [firstpage_image] =>[orig_patent_app_number] => 09788477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494519 [patent_doc_number] => 06342488 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Phosphonorisperidone and sulforisperidone compositions and methods' [patent_app_type] => B1 [patent_app_number] => 09/762968 [patent_app_country] => US [patent_app_date] => 2001-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3220 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342488.pdf [firstpage_image] =>[orig_patent_app_number] => 09762968 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7093862 [patent_doc_number] => 20010034367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Compositions and methods for the treatment of cystic fibrosis' [patent_app_type] => new [patent_app_number] => 09/783029 [patent_app_country] => US [patent_app_date] => 2001-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7234 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034367.pdf [firstpage_image] =>[orig_patent_app_number] => 09783029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000548 [patent_doc_number] => 20020028761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Neurotherapeutic use of carboxypeptidase inhibitors' [patent_app_type] => new [patent_app_number] => 09/783201 [patent_app_country] => US [patent_app_date] => 2001-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 23426 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028761.pdf [firstpage_image] =>[orig_patent_app_number] => 09783201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1459083 [patent_doc_number] => 06426342 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-07-30 [patent_title] => 'Use of -lactamase inhibitors as neuroprotectants' [patent_app_type] => B2 [patent_app_number] => 09/782507 [patent_app_country] => US [patent_app_date] => 2001-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3330 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/426/06426342.pdf [firstpage_image] =>[orig_patent_app_number] => 09782507 [rel_patent_id] =>[rel_patent_doc_number] =>)